Feb 18, 2026 07:19AM
Feb 18, 2026 07:19AM
Feb 12, 2026 06:15PM
Dec 18, 2025 07:31AM
Dec 18, 2025 07:31AM
Nov 13, 2025 05:21PM
Nov 5, 2025 07:16AM Appili Therapeutics announces C$750,000 private placement
Nov 5, 2025 07:16AM
May 2, 2025 09:00AM
Apr 17, 2025 08:15AM
Apr 16, 2025 08:15AM
Apr 14, 2025 08:15AM
Apr 11, 2025 08:15AM
Apr 2, 2025 08:15AM Appili President and CEO, Don Cilla Will Join Aditxt Co-founder and CEO, Amro Albanna, at the Aditxt Weekly Update on April 4, 2025
Mar 28, 2025 08:15AM
Mar 24, 2025 08:15AM
Mar 18, 2025 07:22AM
Mar 17, 2025 08:15AM
Mar 12, 2025 04:15PM
Mar 6, 2025 08:15AM
Mar 6, 2025 08:15AM Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome
Feb 21, 2025 08:15AM
Feb 21, 2025 08:15AM
Feb 14, 2025 05:06PM
Feb 13, 2025 08:15AM
Jan 13, 2025 08:15AM
Dec 12, 2024 08:15AM
Nov 14, 2024 07:15AM Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
Nov 8, 2024 08:35AM
Nov 8, 2024 08:30AM
Nov 7, 2024 08:30AM
Nov 6, 2024 08:30AM
Oct 31, 2024 08:30AM
Oct 30, 2024 05:00PM
Oct 29, 2024 08:15AM Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives
Oct 28, 2024 08:15AM
Oct 21, 2024 08:15AM
Oct 10, 2024 08:15AM
Oct 10, 2024 07:13AM
Oct 9, 2024 10:52AM
Oct 8, 2024 08:15AM
Oct 3, 2024 08:15AM Aditxt Delivers Shareholder Update and 2024 Year-End Plan
Sep 27, 2024 08:15AM
Sep 27, 2024 08:15AM
Sep 24, 2024 08:15AM
Sep 20, 2024 08:15AM
Sep 9, 2024 08:15AM
Sep 4, 2024 08:15AM
Sep 4, 2024 08:15AM Aditxt Subsidiary Pearsanta Submits a Grant Application Seeking to Advance Clinical Trials for Mitomic® Prostate Test, Targeting Early Detection in High-Risk Patients
Aug 29, 2024 08:15AM

1,154,849 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All